Abstract
During the analysis of the human interleukin (IL)-1β precursor cDNA [1], the open reading frame resulted in a protein with a molecular weight of 31000 Daltons but lacking a signal peptide. The interpretation of this leaderless precursor of IL-1β was rather difficult since it was not clear how the mature form was cleaved naturally. We had expressed an intermediate form of recombinant IL-1β with a molecular weight of 21000 Daltons. This species of IL-1β was biologically weak. Upon cleavage with elastase, an 18000 IL-1β form resulted, which possessed a 100-fold increase in biological activity [2]. The elastase N-terminus was not that of the natural IL-1β reported in 1985 by the Belgians which had an N-terminus at alanine 117 [3]. That N-terminus indicated no specific cleavage protease and therefore, it remained unclear for several years exactly how and what protease cleaved precursor IL-1β into a mature peptide with an N-terminus at alanine 117. The discovery of the IL-1β converting enzyme (ICE) as a unique intracellular protease opened a door on an entirely new area of cytokine biology and inflammation in that there are intracellular proteases which function to cleave proteins which lack a classic signal peptide. ICE was the first enzyme of this class described for cutting the precursor for IL-1β; other members of the ICE family were clearly involved in other intracellular biological processes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Auron PE, Webb AC, Rosenwasser LJ, et al (1984) Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA 81:7907–7911
Dinarello CA, Cannon JG, Mier JW, et al (1986) Multiple biological activities of human recombinant interleukin 1. J Clin Invest 77:1734–1739
Van Damme J, De Ley M, Opdenakker G, Billiau A, De Somer P (1985) Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature 314: 266–268
Wilson KP, Black JA, Thomson JA, et al (1994) Structure and mechanism of interleukin-1β converting enzyme. Nature 370:270–275
Gu Y, Wu J, Faucheu C, et al (1995) Interleukin-1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 14:1923–1931
Alnemri ES, Livingston DJ, Nicholson DW, et al (1996) Human ICE/CED-3 protease nomenclature. Cell 87:171
Walker NP, Talanian RV, Brady KD, et al (1994) Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/pl0)2 homodimer. Cell 78:343–352
Irmler M, Hertig S, MacDonald HR, et al (1995) Granzyme A is an interleukin-1β-converting enzyme. J Exp Med 181:1917–1922
Higgins GC, Foster JL, Postlethwaite AE (1994) Interleukin-1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro. J Exp Med 180:607–614
Higgins GC, Foster JL, Postlethwaite AE (1993) Synthesis and biological activity of human interleukin-1β propiece in vitro. Arthritis Rheum 39: SI53 (Abst)
Thornberry NA, Bull HG, Calaycay JR, et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356:768–774
Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia R (1992) Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267: 24161–24164
Mignatti P, Rifkin DB (1991) Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? J Cell Biochem 47:201–217
Singer II, Scott S, Chin J, et al (1995) The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J Exp Med 182:1447–1459
Li P, Allen H, Banerjee S, et al (1995) Mice deficient in interleukin-1 converting enzyme (ICE) are defective in production of mature interleukin-1β and resistant to endotoxic shock. Cell 80:401–411
Kuida K, Lippke JA, Ku G, et al (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000–2003
Fantuzzi G, Zheng H, Faggioni R, et al (1996) Effect of endotoxin in IL-1β-deficient mice. J Immunol 157:291–296
Gu Y, Kuida K, Tsutsui H, et al (1997) Activation of interferon-y inducing factor mediated by interleukin-1β converting enzyme. Science 275:206–209
Ghayur T, Banerjee S, Hugunin M, et al (1997) Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619–623
Car BD, Eng VM, Schnyder B, et al (1994) Interferon y receptor deficient mice are resistant to endotoxic shock. J Exp Med 179:1437–1444
Doecke WD, Randow F, Syrbe U, et al (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678–681
Nakamura K, Okamura H, Wada M, Nagata K, Tamura T (1989) Endotoxin-induced serum factor that stimulates gamma interferon production. Infect Immun 57:590–595
Nakamura K, Okamura H, Nagata K, Komatsu T, Tamura T (1993) Purification of a factor which provides a costimulatory signal for gamma interferon production. Infect Immun 61: 64–70
Okamura H, Nagata K, Komatsu T, et al (1995) A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 63: 3966–3972
Okamura H, Tsutsui H, Komatsu T, et al (1995) Cloning of a new cytokine that induces interferon-y. Nature 378:88–91
Heremans H, van Damme J, Dillen C, Dikman R, Billiau A (1990) Interferon-y, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock in mice. J Exp Med 171: 1853–1861
Ushio S, Namba M, Okura T, et al (1996) Cloning of the cDNA for human IFN-y-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 156:4274–4279
Robinson D, Shibuya K, Mui A, et al (1997) IGIF does not drive Thl development but synergizes with IL-12 for interferon-y production and activates IRAK and NFKB. Immunity 7:571–581
Hunter CA, Timans J, Pisacane P, et al (1997) Comparison of the effects of interleukin-la, interleukin-1β and interferon-y inducing factor on the production of interferon-y by natural killer. Eur J Immunol 27:2787–2792
Kohno K, Kataoka J, Ohtsuki T, et al (1997) IFN-y-inducing factor (IGIF) is a co-stimulatory factor on the activation of Thl but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158:1541–1550
Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H (1997) Interferon-y-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine Thelper cells. Cell Immunol 173:230–235
Tsutsui H, Nakanishi K, Matsui K, et al (1996) IFN-y-inducing factor up-regulates Fas ligandmediated cytotoxic activity of murine natural killer cell clones. J Immunol 157:3967–3973
Ohtsuki T, Micallef MJ, Kohno K, Tanimoto T, Ikeda M, Kurimoto M (1997) Interleukin-18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 17:3253–3258
Bazan JF, Timans JC, Kaselein RA (1996) A newly defined interleukin-1? Nature 379:591
Udagawa N, Horwood NJ, Elliot J, et al (1997) Interleukin-18 is produced by osteoblasts and acts via granulocyte macrophage colony-stimulating factor and not via interferon-y to inhibit osteoclast formation. J Exp Med 185:1005–1012
Torigoe K, Ushio S, Okura T, et al (1997) Purification and characterization of the human interleukin-18 receptor. J Biol Chem 272:25737–25742
Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE (1996) IL-lRrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-IR AcR J Biol Chem 271:3967–3970
Thomassen E, Bird TA, Renshaw BR, Kennedy MK, Sims JE (1998) Binding of interleukin-18 to the interleukin-1 receptor homologous receptor, IL-lRrpl leads to activation of signaling pathways similar to those used by interleukin-1. J Interferon Cytokine Res 18:1077–1088
Yoshimoto T, Takeda K, Tanaka T, et al (1998) IL-12 upregulates IL-18 receptor expression on T cells, Thl cells and B cells: synergism with IL-18 for IFN-y production. J Immunol 161: 3400–3407
Born TL, Thomassen E, Bird TA, Sims JE (1998) Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling. J Biol Chem 273:29445–29450
Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem 270:13757–13765
Sims JE, Gayle MA, Slack JL, et al (1993) Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 90:6155–6159
Novick D, Kim SH, Fantuzzi G, Reznikov L, Dinarello CA, Rubinstein M (1999) lnterleukin-18 binding protein: a novel modulator of the Thl cytokine response. Immunity 10:127–136
Novick D, Engelmann H, Wallach D, Rubinstein M (1989) Soluble cytokine receptors are present in normal human urine. J Exp Med 170:1409–1414
Engelmann H, Novick D, Wallach D (1990) Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 265:1531–1536
Novick D, Cohen B, Rubinstein M (1994) The human interferon α/ß receptor: characterization and molecular cloning. Cell 77:391–400
Novick D, Engelmann H, Wallach D, Leitner O, Revel M, Rubinstein M (1990) Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. J Chromat 510:331–337
Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA (1998) IL-18 regulation of IFN-y production and cell proliferation as revealed in interleukin-1β converting enzymedeficient mice. Blood 91:2118–2125
Hunter CA, Chizzonite R, Remington JS (1995) IL-1β is required for IL-12 to induce the production of IFN-y by NK cells. J Immunol 155:4347–4354
Croston GE, Cao Z, Goeddel DV (1995) NFkB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 270:16514–16517
Martin MU, Falk W (1997) The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur Cytokine Netw 8:5–17
O’Neill LAJ, Greene C (1998) Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63: 650–657
Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU (1997) The interleukin-1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272:7727–7731
Huang J, Gao X, Li S, Cao Z (1997) Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 94: 12829–12832
Cao Z (1998) Signal transduction of interleukin-1. Eur Cytokine Netw 9:378 (Abst)
Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV (1996) Interleukin-1 receptor activating kinase. Nature 383:443–446
Mahnin NL, Boldin MP, Kovalenko AV, Wallach D (1997) MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385:540–544
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive I kappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548–554
Kojima H, Takeuchi M, Ohta T, et al (1998) lnterleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem Biophys Res Commun 244:183–186
Adachi O, Kawai T, Takeda K, et al (1998) Targeted disruption of the MyD88 gene results in loss of lL-1-and IL-18-mediated function. Immunity 9:143–150
Shapiro L, Puren AJ, Barton HA, et al (1998) lnterleukin-18 stimulates HIV type 1 in monocytic cells. Proc Natl Acad Sci USA 95:12550–12555
Tsuji-Takayama K, Matsumoto S, Koide K, et al (1997) lnterleukin-18 induces activation and association of p56lck and MAPK in a murine THl clone. Biochem Biophys Res Commun 237:126–130
Puren AJ, Fantuzzi G, Gu Y, Su MSS, Dinarello CA (1998) lnterleukin-18 (IFN-y-inducing factor) induces IL-1β and IL-8 via TNFa production from non-CD 14-I-human blood mononuclear cells. J CHn Invest 101:711–724
Luster AD (1998) Chemokines — chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–445
Matsimoto S, Tsuji-Takayama K, Aizawa Y, et al (1997) lnterleukin-18 activates NFkB in murine T helper type I cells. Biochem Biophys Res Commun 234:454–457
Mühl H, Dinarello CA (1997) Macrophage inflammatory protein-la production from LPS-stimulated human adherent peripheral blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor NG-monomethyl-L-arginine. J Immunol 159:5063–5069
Kohka H, Yoshino T, Iwagaki H, et al (1998) Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 64:519–527
Dao T, Mehal WZ, Crispe IN (1998) IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 161:2217–2222
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dinarello, C.A. (2002). Interleukin-1β and Interleukin-18: Two Cytokine Precursors for Interleukin-1 β Converting Enzyme (Caspase-1). In: Marshall, J.C., Cohen, J. (eds) Immune Response in the Critically Ill. Update in Intensive Care Medicine, vol 31. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57210-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-57210-4_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42589-2
Online ISBN: 978-3-642-57210-4
eBook Packages: Springer Book Archive